August 7, 2025 - 22:38

Advanced Micro Devices Inc. has made significant strides in the realm of artificial intelligence by partnering with Arteris Inc. to license its FlexGen network-on-chip interconnect technology. This strategic collaboration, announced on August 4, aims to bolster AMD's upcoming AI chiplet designs, promising enhanced performance and efficiency.
The integration of Arteris' advanced interconnect technology is expected to play a crucial role in optimizing data flow and connectivity within AMD's next-generation chiplets. As the demand for AI-driven solutions continues to surge, this partnership positions AMD to leverage cutting-edge innovations that can meet the evolving needs of the market.
Industry analysts view this move as a pivotal step for AMD, which is already recognized as a leading player in the semiconductor space. By incorporating Arteris' technology, AMD not only reinforces its commitment to developing high-performance AI solutions but also strengthens its competitive edge against rivals in the rapidly advancing tech landscape.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...